Company intelligence / Profile preview

Intema

Moscow, Moscow, Russia
Ownership
Private
Development stage
Other
01

Overview

Intema is a Russian biotechnology and pharmaceutical company specializing in the development and production of original medicinal products based on synthetic peptides and recombinant proteins. The company's flagship products include Gepon, a synthetic peptide with immunomodulatory and antiviral properties, and Rexod, a recombinant human superoxide dismutase used for its potent antioxidant and anti-inflammatory effects. Intema focuses on therapeutic areas such as immunology, infectious diseases, and inflammatory conditions. Based in Moscow, the company maintains a presence in the Russian pharmaceutical market through its proprietary research and manufacturing capabilities.

Therapeutic areas
OncologyImmunologyInfectious Diseases
Modalities
PeptidesRecombinant protein
Industry
Biotech
02

Partnerships

Institute of Immunology of the Federal Medical-Biological Agency of Russia

Beyond the preview

Go deeper on Intema.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intema.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call